Pantoloc 20 mg enterotabletter デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

pantoloc 20 mg enterotabletter

takeda pharma a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg

Pantoloc 40 mg enterotabletter デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

pantoloc 40 mg enterotabletter

takeda pharma a/s - pantoprazolnatriumsesquihydrat - enterotabletter - 40 mg

Pantoloc 40 mg pulver til injektionsvæske, opløsning デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

pantoloc 40 mg pulver til injektionsvæske, opløsning

takeda pharma a/s - pantoprazolnatriumsesquihydrat - pulver til injektionsvæske, opløsning - 40 mg

Vepicombin Novum 1,5 Mill. IE filmovertrukne tabletter デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

vepicombin novum 1,5 mill. ie filmovertrukne tabletter

takeda pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1,5 mill. ie

Vepicombin Novum 1 Mill. IE filmovertrukne tabletter デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

vepicombin novum 1 mill. ie filmovertrukne tabletter

takeda pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 1 mill. ie

Takhzyro 欧州連合 - デンマーク語 - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioødemer, arvelige - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Veyvondi 欧州連合 - デンマーク語 - EMA (European Medicines Agency)

veyvondi

baxalta innovations gmbh - vonicog alfa - von willebrand sygdomme - antihemorrhagics - veyvondi er indiceret hos voksne (18 år og ældre) med von willebrand sygdom (vwd), når desmopressin (ddavp) behandlingen alene er ineffektive eller ikke indiceret til behandling af blødning og kirurgisk blødning - forebyggelse af kirurgiske blødninger. veyvondi bør ikke anvendes i behandling af hæmofili a.

Rymphysia 1000 mg pulver og solvens til infusionsvæske, opløsning デンマーク - デンマーク語 - Lægemiddelstyrelsen (Danish Medicines Agency)

rymphysia 1000 mg pulver og solvens til infusionsvæske, opløsning

takeda manufacturing austria ag - alfa-1 proteinaseinhibitor, humant - pulver og solvens til infusionsvæske, opløsning - 1000 mg

Livtencity 欧州連合 - デンマーク語 - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfektioner - antivirale midler til systemisk anvendelse - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antivirale agenter.

Qdenga 欧州連合 - デンマーク語 - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vacciner - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.